Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading pharmaceutical startup seeks an Interim Medical & Scientific Affairs Lead to oversee the UK launch of a novel therapy in ophthalmology. The role requires an experienced ABPI Final Signatory who will shape medical governance and strategic initiatives in a dynamic environment focused on rare diseases. This interim position offers flexibility with remote work and occasional travel opportunities, making it an exciting chance to lead critical efforts ahead of a landmark drug launch.
Client: wax.
Location: Exeter, United Kingdom
Job Category: Other
EU work permit required: Yes
Job Views: 3
Posted: 10.06.2025
Expiry Date: 25.07.2025
Interim Medical & Scientific Affairs Lead (Final Signatory)
Location: UK/Remote
Start: June/July 2025
Focus: Rare Disease | Ophthalmology
An exciting opportunity for an experienced ABPI Final Signatory to lead the Medical & Scientific Affairs function for the UK launch of a first-in-class orphan-designated therapy in ophthalmology.
This is a strategic interim role supporting early access, governance, and scientific engagement ahead of a landmark UK launch in 2026.
This is a startup situation, so you will be shaping the medical governance framework, driving scientific strategy, and partnering cross-functionally to ensure a successful pre-launch phase within a lean, agile setup.
Contract: Approximately 6–9 months, through to post-launch readiness.
If you are interested, please get in touch to arrange a confidential discussion.
#MedicalAffairs #InterimRole #ABPIFinalSignatory #RareDiseases #OrphanDrugs #Ophthalmology #EarlyAccess #HealthcareLeadership #MedicalStrategy #PharmaceuticalIndustry #LifeSciencesJobs #MedicalDirector #ContractRoles #BiotechJobs #LaunchExcellence #HTA #NICE #ClinicalDevelopment #PatientAccess #Compassionate Use